161 related articles for article (PubMed ID: 31727254)
1. Quantitative analysis of the T cell receptor repertoire.
Uddin I; Woolston A; Peacock T; Joshi K; Ismail M; Ronel T; Husovsky C; Chain B
Methods Enzymol; 2019; 629():465-492. PubMed ID: 31727254
[TBL] [Abstract][Full Text] [Related]
2. An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
Uddin I; Joshi K; Oakes T; Heather JM; Swanton C; ; Chain B
Methods Mol Biol; 2019; 1884():15-42. PubMed ID: 30465193
[TBL] [Abstract][Full Text] [Related]
3. The Intra-Tumoral T Cell Receptor Repertoire: Steps Towards a Useful Clinical Biomarker.
Nageswaran G; Byrne S; Veeriah S; Chain B
Methods Mol Biol; 2022; 2574():135-158. PubMed ID: 36087200
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and Versatile.
Oakes T; Heather JM; Best K; Byng-Maddick R; Husovsky C; Ismail M; Joshi K; Maxwell G; Noursadeghi M; Riddell N; Ruehl T; Turner CT; Uddin I; Chain B
Front Immunol; 2017; 8():1267. PubMed ID: 29075258
[TBL] [Abstract][Full Text] [Related]
5. Analysis of TCR β CDR3 sequencing data for tracking anti-tumor immunity.
Zhang J; Ji Z; Smith KN
Methods Enzymol; 2019; 629():443-464. PubMed ID: 31727253
[TBL] [Abstract][Full Text] [Related]
6. High-throughput discovery of cancer-targeting TCRs.
Bunse L; Green EW; Platten M
Methods Enzymol; 2019; 629():401-417. PubMed ID: 31727251
[TBL] [Abstract][Full Text] [Related]
7. High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities.
Heather JM; Ismail M; Oakes T; Chain B
Brief Bioinform; 2018 Jul; 19(4):554-565. PubMed ID: 28077404
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
Schrama D; Ritter C; Becker JC
Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
[TBL] [Abstract][Full Text] [Related]
9. T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing.
Werner L; Dor C; Salamon N; Nagar M; Shouval DS
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522509
[TBL] [Abstract][Full Text] [Related]
10. TRIg: a robust alignment pipeline for non-regular T-cell receptor and immunoglobulin sequences.
Hung SJ; Chen YL; Chu CH; Lee CC; Chen WL; Lin YL; Lin MC; Ho CL; Liu T
BMC Bioinformatics; 2016 Oct; 17(1):433. PubMed ID: 27782801
[TBL] [Abstract][Full Text] [Related]
11. The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes.
de Greef PC; Oakes T; Gerritsen B; Ismail M; Heather JM; Hermsen R; Chain B; de Boer RJ
Elife; 2020 Mar; 9():. PubMed ID: 32187010
[TBL] [Abstract][Full Text] [Related]
12. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
[TBL] [Abstract][Full Text] [Related]
13. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
Ye B; Smerin D; Gao Q; Kang C; Xiong X
Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
[TBL] [Abstract][Full Text] [Related]
14. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
[TBL] [Abstract][Full Text] [Related]
15. The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy.
Han J; Lotze MT
Methods Mol Biol; 2020; 2055():369-397. PubMed ID: 31502161
[TBL] [Abstract][Full Text] [Related]
16. High-throughput and single-cell T cell receptor sequencing technologies.
Pai JA; Satpathy AT
Nat Methods; 2021 Aug; 18(8):881-892. PubMed ID: 34282327
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor and B-cell receptor repertoire profiling in adaptive immunity.
Minervina A; Pogorelyy M; Mamedov I
Transpl Int; 2019 Nov; 32(11):1111-1123. PubMed ID: 31250479
[TBL] [Abstract][Full Text] [Related]
18. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Han Y; Li H; Guan Y; Huang J
Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
[TBL] [Abstract][Full Text] [Related]
19. The methods and advances of adaptive immune receptors repertoire sequencing.
Liu H; Pan W; Tang C; Tang Y; Wu H; Yoshimura A; Deng Y; He N; Li S
Theranostics; 2021; 11(18):8945-8963. PubMed ID: 34522220
[TBL] [Abstract][Full Text] [Related]
20. T Cell Receptor Repertoire Sequencing.
Lin H; Peng Y; Chen X; Liang Y; Tian G; Yang J
Methods Mol Biol; 2020; 2204():3-12. PubMed ID: 32710310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
